PMID: 11907517Mar 22, 2002Paper

Methotrexate treatment for refractory subacute cutaneous lupus erythematosus

Journal of the American Academy of Dermatology
A KuhnP Lehmann

Abstract

Methotrexate is beneficial in rheumatoid arthritis and has been used in small studies of patients with systemic lupus erythematosus. We describe a patient with severe subacute cutaneous lupus erythematosus refractory to therapy with antimalarials and corticosteroids. Treatment with methotrexate resulted in complete clearing of the skin lesions without any side effects.

Citations

Jun 20, 2015·Journal of Immunology Research·Lihua DuanGuixiu Shi
Aug 11, 2020·Arthritis & Rheumatology·Robert Borucki, Victoria P Werth
Nov 16, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Joerg WenzelThomas Tüting
Oct 15, 2009·American Journal of Clinical Dermatology·Hobart W Walling, Richard D Sontheimer
Feb 9, 2012·The Australasian Journal of Dermatology·Sarah ShenChristopher J McCormack
Aug 10, 2010·Lupus·A KuhnG Bonsmann
Oct 20, 2004·The British Journal of Dermatology·J P Callen
Jun 20, 2003·American Journal of Clinical Dermatology·Paolo FabbriMarzia Caproni
Jan 16, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Mirjana ZiemerManfred Kunz
Jun 30, 2012·Dermatologic Therapy·Christopher B Hansen, Kevin W Dahle
Jun 2, 2016·Expert Review of Clinical Immunology·Joshua Chang, Victoria P Werth
Oct 22, 2020·Lupus Science & Medicine·Daisy YanVictoria P Werth
Aug 31, 2010·Journal of the American Academy of Dermatology·Annegret KuhnGisela Bonsmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.